• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

Informatics and Computational Safety Analysis Staff (ICSAS)

About ICSAS 

Organization and Responsibilities 

Programs and Activities 

Contact Us 

About ICSAS

The Informatics and Computational Safety Analysis Staff (ICSAS) is part of CDER's Office of Pharmaceutical Science. ICSAS is an applied regulatory research unit that:

  • Develops databases of toxicological and clinical endpoints
  • Transforms data, developing rules for quantifying toxicological and clinical effects
  • Evaluates structure activity relationship (SAR) and data mining software using ICSAS databases
  • Works with software developers to develop toxicology and clinical effects prediction programs through research leveraging partnerships
  • Reduces the use of animals in testing by eliminating non-critical laboratory studies
  • Facilitates the review process by making better use of accumulated scientific knowledge
  • Supplies tools to the pharmaceutical industry to develop better means to identify and eliminate compounds with potentially significant adverse properties early in the drug discovery and development process

Organization and Responsibilities

Informatics and Computational Safety Analysis Director   Joseph F. Contrera, Ph.D. Joseph.Contrera@fda.hhs.gov
Computational Toxicology Manager    Edwin J. Matthews, Ph.D. Edwin.Matthews@fda.hhs.gov
Database Manager   R. Daniel Benz, Ph.D. R.Daniel.Benz@fda.hhs.gov
Computational Toxicologist   Naomi L. Kruhlak, Ph.D. Naomi.Kruhlak@fda.hhs.gov

Programs and Activities

Contact Us

Please send questions or comments concerning the contents of this page to Dan Benz at R.Daniel.Benz@fda.hhs.gov